Skip to content

Cyrus Harmon, Director at Olema Pharmaceuticals, sold OLMA on Jul 24, 2026

Data as of Oct 27

▼ SELL$146K12,500 shares at $11.71Cyrus Harmon DirectorOLMA Olema Pharmaceuticals, Inc.
Watch OLMA
Traded
Jul 24, 2026
Disclosed
Jul 27, 2026
Filed
3 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Cyrus Harmon, Director at Olema Pharmaceuticals, sold OLMA on Jul 24, 2026TRADEDDISCLOSED
OLMASimilar stocks (XLV — its sector index fund), rebased to OLMA's price on the disclosure day
OLMA since disclosure
−41.4%
after the sale
Similar stocks (XLV) since disclosure
+9.7%
XLV — its sector index fund

Change in closing price from Jul 27, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLCyrus Harmon DirectorOLMA Olema Pharmaceuticals, Inc.$145Kdisclosed Jul 27 · filed 4 days after the trade

See every trade on OLMA →